These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7101268)

  • 21. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis: Indian experience in the last thirty years.
    Jain S; Maheshwari MC
    Neuroepidemiology; 1985; 4(2):96-107. PubMed ID: 3913869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis: HLA studies in Italy.
    Conighi C
    Ital J Neurol Sci; 1987 Jun; Suppl 6():41-3. PubMed ID: 3498705
    [No Abstract]   [Full Text] [Related]  

  • 25. HLA-A & HLA-B antigens in multiple sclerosis, motor neuron disease & Duchenne muscular dystrophy.
    Mehta MM; Chablani UA; Contractor NM; Bhatia HM; Singhal BS; Mondkar VP; Desai AD
    Indian J Med Res; 1986 May; 83():519-21. PubMed ID: 3733208
    [No Abstract]   [Full Text] [Related]  

  • 26. Major histocompatibility complex class I and II antigens frequencies in Baloch ethnic group living in the southeast region of Iran.
    Khazaei HA; Aghamohammadi A; Rezaei N; Nikbin B; Khosravi MA; MiriMoghaddam I
    Transplant Proc; 2004 Jun; 36(5):1302-4. PubMed ID: 15251317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class I and II antigens in South African Indians with NIDDM.
    Omar MA; Hammond MG; Motala AA; Seedat MA
    Diabetes; 1988 Jun; 37(6):796-9. PubMed ID: 3384181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA antigens and multiple sclerosis in Greeks.
    Georgaras A; Constantopoulos C; Lygidacis C; Zervas J
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):751-2. PubMed ID: 6747655
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
    Pálffy G; Gyódi E; Petrányi G
    Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HLA antigens in multiple sclerosis].
    Vymazal J; Krásenská J; Korinková P; Májský A
    Cesk Neurol Neurochir; 1980 Sep; 43(5):284-9. PubMed ID: 7418054
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution of HLA-SB antigens in multiple sclerosis.
    Moen T; Stien R; Bratlie A; Bondevik E
    Tissue Antigens; 1984 Aug; 24(2):126-7. PubMed ID: 6593898
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histocompatibility antigens in retrobulbar neuritis and multiple sclerosis].
    Zavalishin IA; Nevskaia OM; Kulov BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):55-8. PubMed ID: 2750383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current problems in multiple sclerosis (immunogenetic aspect) (review of the literature)].
    Khondkarian OA; Zavalishin IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):292-300. PubMed ID: 76384
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple sclerosis--relation between HLA haplotype A25, B18 and disease progression.
    Meyer-Rienecker HJ; Wegener S; Hitzschke B; Richter KV
    Acta Neurol Scand; 1982 Dec; 66(6):709-12. PubMed ID: 6819759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.
    Miller DH; Hornabrook RW; Dagger J; Fong R
    J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):43-6. PubMed ID: 3457100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attempts at a demonstration of cross reactivity between the HLA- antigens A2 and B12 or A1 and B8].
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):463-8. PubMed ID: 2414177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis.
    Brautbar C; Cohen I; Kahana E; Alter M; Jorgensen F; Lamm L
    Tissue Antigens; 1977 Oct; 10(4):291-302. PubMed ID: 72427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA antigens in multiple sclerosis.
    Sachs JA
    Proc R Soc Med; 1977 Dec; 70(12):869-71. PubMed ID: 341175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.